Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Weibo Experienced a Surge in Advertising Revenue Worth USD 427 Mn in Q1 2022
On June 1, China’s leading social media platform Weibo released its annual financial statements for the first quarter of 2022. The company’s advertising revenue reached USD 427 million, up 10% year on year.
Jun 03, 2022 12:59 AM
Hong Kong IPO at a Glance: Weibo Corporation
The Twitter-like platform completed its secondary listing on December 8, 2021.
Dec 08, 2021 10:03 PM
The Development of China's New Generation Information Technology
Sep 21, 2023 11:46 PM
An Entrepreneur and Her New Journey to Globalization
Sep 21, 2023 05:40 PM
EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part I）
Sep 21, 2023 04:43 PM
Robooter: Structuring New Ecology for Elderly Care
Sep 20, 2023 06:17 PM